Yahoo Web Search

  • FirefoxTry Yahoo Search on Firefox »
    1. Sort by

    1. Glaxo recalls flu vaccine due to potency problem

      Associated Press via Yahoo! NewsApr 17 12:26 PM

      GlaxoSmithKline is recalling remaining doses of a popular four-in-one flu vaccine because of effectiveness problems. The company alerted U.S. customers Tuesday that the vaccine can lose potency over time ...

    2. Title: Inhaled Measles Vaccine Falls Short of Injected Version in Study Category: Health News Created: 4/15/2015 12:00:00 AM Last Editorial Review: 4/16/2015 12:00:00 AM

    3. Title: Ebola Vaccine Trial Begins in Sierra Leone: CDC Category: Health News Created: 4/14/2015 12:00:00 AM Last Editorial Review: 4/15/2015 12:00:00 AM

    4. A new Ebola vaccine study starting in Sierra Leone will test the vaccine in thousands of people who are working to fight the epidemic, health officials said today

    5. GlaxoSmithKline is recalling a popular four-in-one flu vaccine distributed throughout the U.S. because its effectiveness can decline over time.

    6. Research and Markets: Global Influenza Vaccine Market Outlook 2020

      Business Wire via Yahoo! FinanceApr 16 6:48 AM

      Research and Markets has announced the addition of the "Global Influenza Vaccine Market Outlook 2020" report to

    7. Ebola vaccine trial begins in Sierra Leone

      AFP via Yahoo! NewsApr 14 12:04 PM

      Thousands of healthcare workers in areas of Sierra Leone that are grappling with Ebola will now begin receiving an experimental vaccine against the often deadly virus, officials said Tuesday. The vaccine candidate, rVSV-ZEBOV, was developed by the Public Health Agency of Canada and licensed to NewLink Genetics and Merck pharmaceuticals. It will be given to 6,000 healthcare workers and other ...

    8. Merck (MRK) and NewLink Genetics's Ebola vaccine candidate, rVSV-ZEBOV-GP (V920), enters third phase III study in Sierra Leone.

    9. WASHINGTON (AP) — GlaxoSmithKline is recalling remaining doses of a popular four-in-one flu vaccine because of an effectiveness problems.

    10. Pentavalent vaccine worth $1.3 million, enough to vaccinate 400,000 infants against five potentially deadly diseases, has spoiled in a storage room at the National Health Services (NHS) of Pakistan, media reported on Wednesday.

    1. Ads
      related to vaccine
    1. 123455,148 results